BET BRD4 inhibitor compound II-25
CAS: 1660117-38-3
Ref. 3D-KRC11738
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
BET BRD4 inhibitor compound II-25 belongs to a class of protein inhibitors. It is orally available and can inhibit cancer cells in vitro. BET BRD4 inhibitor compound II-25 has been shown to induce cell maturation and apoptosis in myeloid leukemia cells. This drug also inhibits the methyltransferase activity of the enzyme, thereby preventing the production of inflammatory cytokines that cause inflammation. In addition, this drug has shown potential as an anticancer therapeutic by inhibiting cancer cell proliferation and inducing tumor necrosis in vivo. It is possible that BET BRD4 inhibitor compound II-25 may function as a toll-like receptor modulator because it can block TLR signaling pathways in mice.
Propriedades químicas
Consulta técnica sobre: 3D-KRC11738 BET BRD4 inhibitor compound II-25
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
